Alonso, Juli http://orcid.org/0000-0002-0828-2925
Pareto, Deborah http://orcid.org/0000-0001-7356-3769
Alberich, Manel http://orcid.org/0000-0002-4132-0620
Kober, Tobias http://orcid.org/0000-0001-7598-9456
Maréchal, Bénédicte http://orcid.org/0000-0001-7866-2854
Lladó, Xavier http://orcid.org/0000-0003-2777-3479
Rovira, Alex http://orcid.org/0000-0002-2132-6750
Funding for this research was provided by:
La Fundació la Marató de TV3
Retos de Investigación (DPI2017-86696-R)
Article History
Received: 18 November 2019
Revised: 14 May 2020
Accepted: 19 May 2020
First Online: 28 May 2020
Compliance with ethical standards
:
: Juli Alonso declares that he has no conflicts of interest. Deborah Pareto has received speaking honoraria from Novartis and Sanofi-Genzyme. Manel Alberich is sponsored by Novartis Farmacéutica SA Barcelona (Spain). Tobias Kober is an employee of Siemens Healthcare AG, Switzerland. Bénédicte Maréchal is an employee of Siemens Healthcare AG, Switzerland. Xavier Lladó declares that he has no conflicts of interest. Alex Rovira serves on scientific advisory boards for Novartis, Sanofi-Genzyme, Icometrix, and OLEA Medical, and has received speaker honoraria from Bayer, Sanofi-Genzyme, Bracco, Merck-Serono, Teva Pharmaceutical Industries Ltd, Novartis, Roche, and Biogen Idec.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the hospital research and ethics committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.